Clinical Trials Directory

Trials / Completed

CompletedNCT01931436

Pharmacokinetics Study of Qing'E Pill

A Single-site, Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics of the Main Components of Qing'E Pill (a Chinese Medicine Formula) Into the Blood in Chinese Menopausal Women

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Shanghai University of Traditional Chinese Medicine · Academic / Other
Sex
Female
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the pharmacokinetics of single and multiple doses of Qing'E pills in Chinese menopause volunteers. The main components of Qing'E pill into the blood such as psoralen and Isopsoralen will be detected.

Conditions

Interventions

TypeNameDescription
DRUGQing'E pillQing'E pill is composed of eucommia, psoralen, walnuts and garlic.

Timeline

Start date
2013-08-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2013-08-29
Last updated
2022-05-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01931436. Inclusion in this directory is not an endorsement.

Pharmacokinetics Study of Qing'E Pill (NCT01931436) · Clinical Trials Directory